UKHSA reports rise in meningococcal disease and urges vaccination catch-up

Teenagers school children walking out of school
SolStock / E+ via Getty Images

The UK Health Security Agency (UKHSA) has reported 378 confirmed cases of invasive meningococcal disease (IMD) – a major cause of meningitis and septicaemia – during 2024-25, with the majority caused by MenB.

The latest figures are consistent with the continued increase following the sharp decline observed during the Covid-19 pandemic.

MenB accounted for 82.6% of all cases (313 of 378) in 2024-25, followed by MenW (11.3%), MenY (3.4%) and MenC (0.8%).

Related Article: Beyond the scales: reframing eating disorder recognition in primary care

Vaccination uptake has declined across both infant and adolescent cohorts. The latest quarterly uptake at 12 months of age for the MenB vaccine fell by 0.3 percentage points to 91.4%.

MenACWY vaccine coverage for Year 9 pupils in the 2023/24 academic year was 72.1% – up 3.5 percentage points from the previous year but below the 88% recorded in 2018/19.

UKHSA has highlighted that all individuals remain eligible for the MenACWY vaccine until their 25th birthday.

Dr Helen Campbell, lead scientist at UKHSA, said: ‘If [someone has] missed out, it is vital they get vaccinated, particularly if they are going to university or colleges where their risk of this often-devastating disease is much higher.’

Related Article: Sharp rise in diabetes cases prompts call for better postnatal support

MenB caused 90% of IMD cases in infants (35 of 39) and all 65 cases in 15- to 19-year-olds last year. It was also responsible for 70% of IMD cases in adults aged 25 and over (119 of 169).

MenW cases increased to 43 in 2024-25, up from 17 the previous year, with some cases associated with travel to Saudi Arabia.

However, the UKHSA said cases remained well below the 218 cases reported in 2015-16 – which was the year the MenACWY vaccine was introduced.

Related Article: Novo Nordisk launch new 7.2mg single-dose Wegovy pen

Public health minister Ashley Dalton said: ‘These latest figures are a stark reminder meningitis remains a serious threat to children and young adults. A simple vaccination could save a life or prevent life-changing complications.’

Dr Amanda Doyle, national director for primary care and community services at NHS England, said: ‘Too many children and young people are still not fully vaccinated against meningitis – a debilitating disease that can strike quickly and cause life-changing health complications and be deadly if not treated promptly.’

Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Want news like this straight to your inbox?
Register for full access to the site and our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.